Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977–86. https://doi.org/10.1056/NEJM199309303291401.

Article  Google Scholar 

Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med. 1993;329:304–9. https://doi.org/10.1056/NEJM199307293290502.

Article  CAS  PubMed  Google Scholar 

Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the accord randomised trial. Lancet. 2010;376:419–30. https://doi.org/10.1016/S0140-6736(10)60576-4.

Article  PubMed  PubMed Central  Google Scholar 

Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N, Reaven PD, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129–39. https://doi.org/10.1056/NEJMoa0808431.

Article  CAS  PubMed  Google Scholar 

Deiss D, Bolinder J, Riveline JP, Battelino T, Bosi E, Tubiana-Rufi N, et al. Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care. 2006;29:2730–2. https://doi.org/10.2337/dc06-1134.

Article  PubMed  Google Scholar 

Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359:1464–76. https://doi.org/10.1056/NEJMoa0805017.

Article  Google Scholar 

Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363:311–20. https://doi.org/10.1056/NEJMoa1002853.

Article  CAS  PubMed  Google Scholar 

Tsunemi A, Sato J, Kurita M, Wakabayashi Y, Waseda N, Koshibu M, et al. Effect of real-life insulin pump with predictive low-glucose management use for 3 months: analysis of the patients treated in a Japanese center. J Diabetes Investig. 2020;11:1564–9. https://doi.org/10.1111/jdi.13288.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Katayama A, Tone A, Watanabe M, Teshigawara S, Miyamoto S, Eguchi J, et al. The hypoglycemia-prevention effect of sensor-augmented pump therapy with predictive low glucose management in Japanese patients with type 1 diabetes mellitus: a short-term study. Diabetol Int. 2020;11:97–104. https://doi.org/10.1007/s13340-019-00408-7.

Article  PubMed  Google Scholar 

Zhong A, Choudhary P, McMahon C, Agrawal P, Welsh JB, Cordero TL, et al. Effectiveness of automated insulin management features of the MiniMed® 640G sensor-augmented insulin pump. Diabetes Technol Ther. 2016;18:657–63. https://doi.org/10.1089/dia.2016.0216.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Müller L, Habif S, Leas S, Aronoff-Spencer E. Reducing hypoglycemia in the real world: a retrospective analysis of predictive low-glucose suspend technology in an ambulatory insulin-dependent cohort. Diabetes Technol Ther. 2019;21:478–84. https://doi.org/10.1089/dia.2019.0190.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Horowitz ME, Kaye WA, Pepper GM, Reynolds KE, Patel SR, Knudson KC, et al. An analysis of medtronic minimed 670G insulin pump use in clinical practice and the impact on glycemic control, quality of life, and compliance. Diabetes Res Clin Pract. 2021;177: 108876. https://doi.org/10.1016/j.diabres.2021.108876.

Article  CAS  PubMed  Google Scholar 

Farrington C. Psychosocial impacts of hybrid closed-loop systems in the management of diabetes: a review. Diabet Med. 2018;35:436–49. https://doi.org/10.1111/dme.13567.

Article  CAS  PubMed  Google Scholar 

Arunachalum S, Velado K, Vigersky RA, Cordero TL. Glycemic outcomes during real-world hybrid closed-loop system use by individuals with type 1 diabetes in the United States. J Diabetes Sci Technol. 2023;17:951–8. https://doi.org/10.1177/19322968221088608.

Article  CAS  PubMed  Google Scholar 

Garg SK, Grunberger G, Weinstock R, Lawson ML, Hirsch IB, DiMeglio LA, et al. Improved glycemia with hybrid closed-loop versus continuous subcutaneous insulin infusion therapy: results from a randomized controlled trial. Diabetes Technol Ther. 2023;25:1–12. https://doi.org/10.1089/dia.2022.0421.

Article  CAS  PubMed  Google Scholar 

Da Silva J, Bosi E, Jendle J, Arrieta A, Castaneda J, Grossman B, et al. Real-world performance of the minimed™ 670G system in Europe. Diabetes Obes Metab. 2021;23:1942–9. https://doi.org/10.1111/dom.14424.

Article  CAS  PubMed  Google Scholar 

Lunati ME, Morpurgo PS, Rossi A, Gandolfi A, Cogliati I, Bolla AM, et al. Hybrid close-loop systems versus predictive low-glucose suspend and sensor-augmented pump therapy in patients with type 1 diabetes: a single-center cohort study. Front Endocrinol. 2022;13: 816599. https://doi.org/10.3389/fendo.2022.816599.

Article  Google Scholar 

Wright EE Jr, Morgan K, Fu DK, Wilkins N, Guffey WJ. Time in range: how to measure it, how to report it, and its practical application in clinical decision-making. Clin Diabetes. 2020;38:439–48. https://doi.org/10.2337/cd20-0042.

Article  PubMed  PubMed Central  Google Scholar 

Battelino T, Danne T, Bergenstal RM, Amiel SA, Beck R, Biester T, et al. Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range. Diabetes Care. 2019;42:1593–603. https://doi.org/10.2337/dci19-0028.

Article  PubMed  PubMed Central  Google Scholar 

Vigersky RA, McMahon C. The relationship of hemoglobin A1C to time-in-range in patients with diabetes. Diabetes Technol Ther. 2019;21:81–5. https://doi.org/10.1089/dia.2018.0310.

Article  CAS  PubMed  Google Scholar 

Ishii H. Development and psychometric validation of the diabetes therapy-related QOL (DTR-QOL) questionnaire. J Med Econ. 2012;15:556–63. https://doi.org/10.3111/13696998.2012.665111.

Article  PubMed  Google Scholar 

Goto H, Mita T, Fujitani Y, Fujimoto S, Takahashi K, Satoh H, et al. Effects of linagliptin versus voglibose on treatment-related quality of life in patients with type 2 diabetes: sub-analysis of the L-STEP study. Endocr J. 2018;65:657–68. https://doi.org/10.1507/endocrj.EJ18-0088.

Article  CAS  PubMed  Google Scholar 

McAuley SA, Lee MH, Paldus B, Vogrin S, de Bock MI, Abraham MB, et al. Six months of hybrid closed-Loop versus manual insulin delivery with fingerprick blood glucose monitoring in adults with type 1 diabetes: a randomized, controlled trial. Diabetes Care. 2020;43:3024–33. https://doi.org/10.2337/dc20-1447.

Article  CAS  PubMed  Google Scholar 

Lal RA, Basina M, Maahs DM, Hood K, Buckingham B, Wilson DM. One year clinical experience of the first commercial hybrid closed-loop system. Diabetes Care. 2019;42:2190–6. https://doi.org/10.2337/dc19-0855.

Article  PubMed  PubMed Central  Google Scholar 

Akiyama T, Yamakawa T, Orime K, Ichikawa M, Harada M, Netsu T, et al. Effects of hybrid closed-loop system on glycemic control and psychological aspects in persons with type 1 diabetes treated with sensor-augmented pump: a prospective single-center observational study. J Diabetes Investig. 2024;15:219–26. https://doi.org/10.1111/jdi.14103.

Article  CAS  PubMed  Google Scholar 

Bjornstad P, Snell-Bergeon JK, Nadeau KJ, Maahs DM. Insulin sensitivity and complications in type 1 diabetes: new insights. World J Diabetes. 2015;6:8–16. https://doi.org/10.4239/wjd.v6.i1.8.

Article  PubMed  PubMed Central  Google Scholar